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S U M M A R Y
Fever occurs frequently in cancer patients, and neoplastic fever is a well-described paraneoplastic
phenomenon in patients with lymphoma, acute leukemias, and renal cell carcinoma. It is also more
commonly encountered in metastatic disease. Treatment options include disease-speciﬁc therapy, non-
steroidal anti-inﬂammatory drugs (NSAIDs), and steroids. Lung cancer is one of the most common
cancers, yet fever as a manifestation of this malignancy has not been emphasized. In this report, we
describe an unusual case of non-metastatic non-small cell lung cancer (NSCLC) presenting with
neoplastic fever at both diagnosis and relapse, responding on each occasion to disease-speciﬁc
treatment, and provide a review of the management of neoplastic fever.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Neoplastic fever is a well-described entity in patients with
lymphoma, acute leukemias, and renal cell carcinoma, although
almost any other cancer can cause neoplastic fever.1,2 We describe
an unusual case of a patient with non-small cell lung cancer
(NSCLC) presenting with neoplastic fever at both diagnosis and
relapse, responding on each occasion to disease-speciﬁc therapy.
2. Case report
A 38-year-old male smoker attended our institution for the
evaluation of coughing, intermittent fever, and night sweats of 2-
month duration. Chest X-ray showed a right upper lobe mass.
Computed tomography (CT) conﬁrmed a 7.5  5 cm right upper
lobe mass with no other signiﬁcant abnormality. Adenocarcinoma
was diagnosed following image-guided biopsy. The patient had a
persistent daily fever above 37.8 8C that was not associated with
tachycardia, chills, or rigors (Figure 1a). On admission, C-reactive
protein (CRP) was 11 mg/dl and the erythrocyte sedimentation
rate (ESR) was 136 mm/h. The white blood cell count (WBC) was
32  109/l and peripheral blood ﬁlm showed a leukemoid reaction.
Physical and laboratory examinations (including blood, urine and
sputum cultures, and sputum acid-fast bacilli) yielded no evidence
of infection. Fever did not respond to adequate empiric antibiotic* Corresponding author. Tel.: +65 6772 5555; fax: +65 6777 5545.
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of the fever within a day after surgery (Figure 1b) and the WBC
normalized within 2 days, strongly corroborating a diagnosis of
neoplastic fever. Unfortunately, the patient relapsed with locally
advanced disease 3 months post-surgery, when he re-presented
with coughing and intermittent fever (Figure 2a). Again, careful
physical and laboratory examinations showed no evidence of
infection. He was treated with radical radiotherapy over 6 weeks,
after which there was complete lysis of the fever (Figure 2b). This
was consistent with a demonstrable response on a post-treatment
CT of the thorax. There was no further fever during subsequent
follow-up.
3. Discussion
Neoplastic fever, deﬁned as fever caused by cancer itself, has
been shown to be the most common cause of fever of unknown
origin (FUO) in patientswith cancer.3 It is awell-described entity in
patients with lymphoma, acute leukemias, and renal cell
carcinoma, although almost any other cancer can cause neoplastic
fever.1,2 It is more frequently encountered in the metastatic
setting, especially to the liver.4,5 The pathophysiology of neoplastic
fever remains uncertain. Research aimed at elucidating the
mechanisms involved suggests the possible role of inﬂammatory
cytokines released by cancer cells, including interleukin (IL)-1, IL-
6, tumor necrosis factor (TNF)-a, and interferon.6,7 Other
mechanisms include tumor necrosis, which may be associated
with the release of TNF and other pyrogens from dead tissue.8
Neoplastic fever in patients with brain metastases is suspected toses. Published by Elsevier Ltd. All rights reserved.
Figure 1. (a) Vitals chart at diagnosis of cancer, demonstrating intermittent fever not accompanied by tachycardia. (b) Vitals chart in the peri-operative period for lung cancer,
demonstrating complete lysis of fever after surgery.
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phospholipase A2.8,9
It is important to distinguish between infectious fever and
neoplastic fever, since the timely administration of appropriate
antimicrobial therapy for speciﬁc infections impacts on out-
come.10,11 As a consequence, such patients are often subjected to
extensive investigations that may be uncomfortable, time-
consuming, and costly. CRP and ESR levels at admission are not
clinically useful in differentiating neoplastic fever from infectious
fever.12 The utility of naproxen in identifying patients with
neoplastic fever has been described,13 although there is a
retrospective study demonstrating conﬂicting results.14
Once the diagnosis is established, the morbidity of neoplastic
fever may be palliated by disease-speciﬁc therapy like surgery,
chemotherapy, or radiotherapy. Whilst the efﬁcacy of surgery in
early stage lung cancer in treating neoplastic fever has beendescribed,15 this is the ﬁrst report of neoplastic fever in locally
relapsed lung cancer responding to radiotherapy alone. In a report
of 17 patients with metastatic breast cancer, seven patients (41%)
responded to systemic anti-neoplastic therapy and fever disap-
peared only in this group of responders.16 NSAIDs such as
naproxen, indomethacin, diclofenac, ibuprofen and rofecoxib have
been used with varying but signiﬁcant efﬁcacy in treating
neoplastic fever.17,18 However, the potential beneﬁts of NSAIDs
should be weighed against possible gastrointestinal side effects.
Furthermore, in some patients with neoplastic fever, fever will
recur if NSAID therapy is discontinued.19 The antipyretic effect of
corticosteroids on neoplastic fever has also been described,
although a small non-randomized retrospective study suggested
that naproxen is superior.20
In summary, this report describes an unusual case of a patient
with non-metastatic NSCLC presenting with neoplastic fever at
Figure 2. (a) Vitals chart at cancer recurrence, demonstrating intermittent fever associatedwith tachycardia. (b) Diary record of temperature during and after radiotherapy for
recurrent cancer, demonstrating lysis of fever after treatment.
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disease-speciﬁc treatment in the form of surgery at diagnosis and
radiotherapy at relapse.
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